BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18984474)

  • 21. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.
    Wobser H; Dorn C; Weiss TS; Amann T; Bollheimer C; Büttner R; Schölmerich J; Hellerbrand C
    Cell Res; 2009 Aug; 19(8):996-1005. PubMed ID: 19546889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase functions in hepatic injury and fibrosis.
    Roderfeld M
    Matrix Biol; 2018 Aug; 68-69():452-462. PubMed ID: 29221811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
    Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
    J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroproliferative disorders and their mechanobiology.
    Huang C; Ogawa R
    Connect Tissue Res; 2012; 53(3):187-96. PubMed ID: 22329637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver fibrosis and cirrhosis--selected cytokines, growth factors and proteins. Part II].
    Wirkowska A; Paczek L
    Przegl Lek; 2011; 68(4):228-30. PubMed ID: 21853679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis.
    Laurent GJ; Chambers RC; Hill MR; McAnulty RJ
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):647-51. PubMed ID: 17635112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.
    Urtasun R; Cubero FJ; Vera M; Nieto N
    Gastroenterology; 2009 Apr; 136(4):1410-22, e1-4. PubMed ID: 19250650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
    Chor JS; Yu J; Chan KK; Go YY; Sung JJ
    J Gastroenterol Hepatol; 2009 May; 24(5):853-9. PubMed ID: 19220659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in chronic inflammatory liver disease.
    Medina J; Arroyo AG; Sánchez-Madrid F; Moreno-Otero R
    Hepatology; 2004 May; 39(5):1185-95. PubMed ID: 15122744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammation and hepatic fibrosis.
    Bissell DM
    Semin Liver Dis; 2010 Aug; 30(3):211-4. PubMed ID: 20665373
    [No Abstract]   [Full Text] [Related]  

  • 31. Liver fibrosis in vitro: cell culture models and precision-cut liver slices.
    Van de Bovenkamp M; Groothuis GM; Meijer DK; Olinga P
    Toxicol In Vitro; 2007 Jun; 21(4):545-57. PubMed ID: 17289342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can matrix metalloproteinase inhibitors provide a realistic therapy in cardiovascular medicine?
    MacFadyen RJ
    Curr Opin Pharmacol; 2007 Apr; 7(2):171-8. PubMed ID: 17317319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of insulin resistance on the progression of chronic liver diseases.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Yoshii J; Yanase K; Namisaki T; Yamazaki M; Moriya K; Tsujimoto T; Kawaratani H; Akahane T; Uemura M; Fukui H
    Int J Mol Med; 2008 Dec; 22(6):801-8. PubMed ID: 19020779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-matrix interaction and hepatic fibrosis.
    Bissell DM
    Prog Liver Dis; 1990; 9():143-55. PubMed ID: 2156289
    [No Abstract]   [Full Text] [Related]  

  • 35. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure.
    Schram K; Sweeney G
    Trends Cardiovasc Med; 2008 Aug; 18(6):199-205. PubMed ID: 19185809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis.
    Park JH; Jo JH; Kim KH; Kim SJ; Lee WR; Park KK; Park JB
    J Gene Med; 2009 Sep; 11(9):824-33. PubMed ID: 19554625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted treatments for cirrhosis.
    Fallowfield JA; Iredale JP
    Expert Opin Ther Targets; 2004 Oct; 8(5):423-35. PubMed ID: 15469393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosomes, fibroblasts, and growth factors: how a worm causes liver scarring.
    Wyler DJ
    New Biol; 1991 Aug; 3(8):734-40. PubMed ID: 1931818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis: a bidirectional model of fibrogenesis and resolution.
    Ramachandran P; Iredale JP
    QJM; 2012 Sep; 105(9):813-7. PubMed ID: 22647759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.